500 mg 1 g le matin ou avec les repas
Some large cohort analyses found a higher risk of psychiatric diagnoses among GLP-1 users compared with people on other diabetes medications, including: 195% higher risk of major depression 106% higher risk of suicidal behavior 108% increased risk of anxiety disorders 1 to 2% of patients , and one analysis suggests people prescribed GLP-1 drugs may already carry a higher baseline risk of depression, rather than the drug directly causing it (4 Trusted Source Risk of Depression with GLP-1 Receptor Agonist Use in Overweight or Obese Adults with Type 2 Diabetes Go to source)(6 Trusted Source Glucagon-like Peptide-1 Medicines in Neurological and Psychiatric Disorders Go to source)
In addition, l-carnitine has shown beneficial effects on cardiovascular health, contributing to optimal heart function and lipid profile management
Beyond that, the evidence is per-compound plus the CagriSema (cag + sema) Phase 3 data as the closest human analog
Altinok, A., et al., The effects of alpha lipoic acid on liver cells damages and apoptosis induced by polyunsaturated fatty acids
The segment of the Blue Cross market most vulnerable to the new policy are members enrolled in fully insured plans where insurers set the terms of coverage